ID: ALA5169735

Max Phase: Preclinical

Molecular Formula: C12H8Cl2N2O3

Molecular Weight: 299.11

Associated Items:

Representations

Canonical SMILES:  [O-][NH+]1c2ccc(O)cc2[NH+]([O-])c2cc(Cl)c(Cl)cc21

Standard InChI:  InChI=1S/C12H8Cl2N2O3/c13-7-4-11-12(5-8(7)14)16(19)10-3-6(17)1-2-9(10)15(11)18/h1-5,15-17H

Standard InChI Key:  AJGGYMWCALORIZ-UHFFFAOYSA-N

Associated Targets(non-human)

Triosephosphate isomerase, glycosomal 493 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 299.11Molecular Weight (Monoisotopic): 297.9912AlogP: 1.70#Rotatable Bonds: 0
Polar Surface Area: 75.23Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.90CX Basic pKa: CX LogP: 1.99CX LogD: 1.99
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.51Np Likeness Score: -0.03

References

1. Beltran-Hortelano I, Alcolea V, Font M, Pérez-Silanes S..  (2022)  Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.,  58  [PMID:35189560] [10.1016/j.bmc.2021.116577]

Source